Longeveron (LGVN) announced leadership updates. The company’s board of directors has appointed Than Powell as interim CEO, effective immediately. He succeeds Wa’el Hashad who transitioned from CEO to pursue other opportunities. The board also appointed Joshua Hare, Longeveron’s founder, chief science officer and current board chair, as executive chairman of the board. Hare and Powell already serve in executive leadership roles for the company. The board plans to conduct a national search to identify a permanent CEO.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LGVN:
- Longeveron Inc. Earnings Call: Progress Amid Challenges
- Longeveron: Buy Rating Backed by Promising Clinical Developments and Strategic Financial Outlook
- Longeveron price target lowered to $3 from $10 at Roth Capital
- Longeveron Inc. Faces Regulatory and Manufacturing Challenges Threatening Financial Stability
- Longeveron Inc. Reports Q2 2025 Financial Results
